Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jinju Lei"'
Publikováno v:
Heliyon, Vol 10, Iss 5, Pp e26859- (2024)
Background: Gliomas, known for their complex and aggressive characteristics, are deeply influenced by the tumor microenvironment. Matrix metalloproteinases (MMPs) play a vital role in shaping this environment, presenting an opportunity for novel trea
Externí odkaz:
https://doaj.org/article/b5f8a1f29dd9421e9d8c07df9e4c8c4f
Autor:
Ruihua Wang, Ying Sun, Bo-Hua Kuang, Xiao Yan, Jinju Lei, Yu-Xin Lin, Jinxiu Tian, Yating Li, Xiaoduo Xie, Tao Chen, Hui Zhang, Yi-Xin Zeng, Jincun Zhao, Lin Feng
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
ABSTRACTReplicating SARS-CoV-2 has been shown to degrade HLA class I on target cells to evade the cytotoxic T-cell (CTL) response. HLA-I downregulation can be sensed by NK cells to unleash killer cell immunoglobulin-like receptor (KIR)-mediated self-
Externí odkaz:
https://doaj.org/article/21dd99f7d5204c5981f5b07eda6a616e
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Immune-related adverse events (irAEs) are common during immune checkpoint inhibitor (ICI) treatment and reported to be associated with good survival. This study evaluated the association between onset timing of irAEs and survival of cance
Externí odkaz:
https://doaj.org/article/4c416b31d8ed40a38bee42ff97f8139c
Supplemental material, sj-pdf-1-tam-10.1177_1758835920980546 for The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis by Huilin Xu, Ximing X
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc2d612fc15c476d3dab15111dd237f2
Publikováno v:
International immunopharmacology. 100
BACKGROUND Immune checkpoint inhibitors (ICI) are increasingly used in hepatocellular carcinoma (HCC) trials. However, the correlations between early endpoints, such as progression free survival (PFS), objective response rate (ORR), and disease contr
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Immune-related adverse events (irAEs) are common during immune checkpoint inhibitor (ICI) treatment and reported to be associated with good survival. This study evaluated the association between onset timing of irAEs and survival of cance
Publikováno v:
World Journal of Gastroenterology
AIM To investigate whether autophagic cell death is involved in hyperthermic sensitization to ionizing radiation in human hepatocellular carcinoma cells, and to explore the underlying mechanism. METHODS Human hepatocellular carcinoma cells were treat
Autor:
Wang, Ruihua, Sun, Ying, Kuang, Bo-Hua, Yan, Xiao, Lei, Jinju, Lin, Yu-Xin, Tian, Jinxiu, Li, Yating, Xie, Xiaoduo, Chen, Tao, Zhang, Hui, Zeng, Yi-Xin, Zhao, Jincun, Feng, Lin
Publikováno v:
Emerging Microbes & Infections; Dec2023, Vol. 12 Issue 1, p1-18, 18p
Autor:
Ruan, Zhaohui, Zhang, Yuetong, Li, Zhaozhi, Jiang, Jiaxin, Luo, Wei, Quan, Qi, Xu, Zihao, Lei, Jinju, Peng, Roujun
Publikováno v:
Clinical & Experimental Medicine; Dec2023, Vol. 23 Issue 8, p5051-5062, 12p
Publikováno v:
Therapeutic Advances in Medical Oncology; 12/18/2020, p1-15, 15p